Status:
COMPLETED
Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training Period
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
15-65 years
Phase:
NA
Brief Summary
Life expectancy of patients with cystic fibrosis has improved dramatically the last few years. Respiratory complications remain the main contributory factor to the morbidity and mortality associated w...
Detailed Description
We hope that regular contact with the coaches or the medical staff will provide self-confidence. Thus, patients will probably be more able to choose a physical activity which will be enjoyable, shared...
Eligibility Criteria
Inclusion
- Man or woman with cystic fibrosis whose diagnosis was documented on clinical history and a test for detecting genetic or sweat test positive
- Patient who signed the informed consent (or parents for patients minors)
- Elderly aged 15 and over
- Patient affiliated with a social security
- Patient against non-cardiac indication of physical
- Patient in stable condition on a respirator with a higher FEV to 1000 ml
- In the case of insulin-dependent diabetes, it must be balanced
- Patient had been informed of the results of the medical examination
- Women of childbearing age have achieved a pregnancy test on urine negative.
Exclusion
- Diabetic patient unbalanced known cardiac pathology
- Patient on transplant list
- Patient major protected
- Patient under guardianship or trusteeship
- Safeguard patient justice
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00792194
Start Date
December 1 2008
End Date
December 1 2014
Last Update
September 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU, Hôpital Civile, Service de Physiologie et Explorations Fonctionnelles
Strasbourg, France